ODENSE, May 18th, 2020 – Ossiform®, We Print Bone™, is pleased to announce that the £2.5 million capital raise through West Hill Capital was heavily oversubscribed. Ossiform® has developed a disruptive and patented technology to be used to produce and supply P3D Bone; 3D printed patient-specific, resorbable bone implants that remodel into real living bone. The first research products have been launched, the P3D Scaffolds, bringing natural bone environments into laboratories.

The raised capital will be used to establish the production line for the P3D Bone and get the product ready for market and to build the sales and marketing platform for the P3D Scaffolds.

“We are very pleased to collaborate with West Hill raising the capital needed to expand our activities and prepare our P3D Bone for the US$3.8 billion bone implant market as well as advancing the Company’s commercialization activities for the P3D Scaffold.”, says Thea Wulff Olesen, CEO of Ossiform®.

Ossiform® has received several awards and grants for developing this technology including the Danish Venture Cup 2017 and Best Nordic Health Tech Startup 2020. In early 2018, Ossiform® received a grant of DKK 450,000 towards a second pig trial from the Danish Innovation Fund. In June 2018, Ossiform® closed a seed investment round of DKK 5.17 million from PreSeed Ventures and business angels and the Company is now doing an investment round A with West Hill Capital. The offering of the private placement has in 2 days been fully subscribed.

Robert Caie, Managing Partner at West Hill Capital, added, “West Hill is delighted to be supporting such an innovative business with a technology that could potentially improve the lives of implant patients through their ability to remodel 3D printed bone into real living bone within the body. Ossiform® could well become the gold standard in bone replacement, the world over.
The Company represents yet another Danish technology business within our portfolio that is excelling within its respective multi-billion dollar market.”

​

Ossiform®

Ossiform® is a Danish MedTech company founded on proprietary technology to 3D print patient-specific, natural and resorbable bone implants. This enables fast ingrowth of bone tissue, remodeling into real living bone, and results in fewer complications. The technology can also be used for 3D printed R&D products, implants with additives, such as antibiotics or other drugs, and even in industries outside healthcare. Website Ossiform – We Print Bone

​

West Hill Capital

West Hill Capital is a leading venture capital firm providing institutional and private investors unrivalled direct access to highly attractive UK and European growth businesses. In recent years, West Hill Capital has raised in excess of £185m for a portfolio of innovative financial services businesses and pioneering technology companies with global potential. Website West Hill Capital: Private Equity and Venture Capital Firm

​For more information, please contact:

Ossiform®
​Thea Wulff Olesen, CEO

​two@ossiform.com

Tel.: +45 26 32 63 32​

​West Hill Capital

Robert Caie, Managing Partner

mjhickson@westhillcapital.co.uk

Tel.: +44 20 34 40 75 58